Invesco Pharmaceuticals ETF
PJP
83 hedge funds and large institutions have $116M invested in Invesco Pharmaceuticals ETF in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 8 closing their positions.
35% more capital invested
Capital invested by funds: $86.2M → $116M (+$30M)
10.42% more ownership
Funds ownership: 21.88% → 32.3% (+10%)
0% more funds holding
Funds holding: 83 → 83 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
35% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$34.2M |
| 2 |
IMC Chicago
Chicago,
Illinois
|
+$3.12M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.67M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.1M |
| 5 |
Jane Street
New York
|
+$853K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$1.56M |
| 2 |
RFA
Reilly Financial Advisors
La Mesa,
California
|
-$1.1M |
| 3 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
-$766K |
| 4 |
LPL Financial
San Diego,
California
|
-$666K |
| 5 |
Morgan Stanley
New York
|
-$619K |
PJP Hedge Fund Activity: Q3 2019 in Review
83 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2019, worth a combined $116M — up 35% from $86.2M a quarter earlier.
Fund positioning in PJP was balanced in Q3 2019: 8 funds opened new positions, 8 closed out, 17 added to existing stakes and 26 trimmed.
The largest buyer was Bank of America, adding an estimated $34.2M. The largest seller was CIBC Private Wealth Group, exiting entirely with an estimated $1.56M sold.
- 83 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $116M of Invesco Pharmaceuticals ETF stock for Q3 2019, up 35% quarter-over-quarter.
- 8 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2019 and 8 closed out, a net change of 0 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2019 was Bank of America, an estimated $34.2M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2019 was CIBC Private Wealth Group, an estimated $1.56M sold.
Based on aggregated 13F filings for Q3 2019.